Manhattan West Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Manhattan West Asset Management's LLY Position: Q1 2026 in Review
Manhattan West Asset Management increased its Eli Lilly (LLY) stake by 5.2% in Q1 2026, buying an estimated $115K and bringing the position to 2,286 shares worth $2.1M. The position accounts for 0.41% of the portfolio, ranked #59.
Manhattan West Asset Management first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $2.34M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Manhattan West Asset Management held 2,286 shares of Eli Lilly worth $2.1M as of Q1 2026.
- Manhattan West Asset Management bought 113 Eli Lilly shares in Q1 2026, an estimated $115K.
- Eli Lilly made up 0.41% of Manhattan West Asset Management's portfolio in Q1 2026, its #59 holding.
- Manhattan West Asset Management first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
- Manhattan West Asset Management's Eli Lilly position peaked at $2.34M in Q4 2025.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Manhattan West Asset Management's 13F filing for Q1 2026, filed 14 May 2026.